Fluorescent Chemosensors for Continuous Glucose Monitoring
Author Information
Author(s): Czarnik Anthony W., James Tony D.
Primary Institution: University of Nevada, Reno
Hypothesis
Can fluorescent chemosensors be developed for long-term continuous glucose monitoring?
Conclusion
The study demonstrates that boronic acid-based fluorescent chemosensors can be effectively used for long-term continuous glucose monitoring, leading to the development of the Eversense CGM system.
Supporting Evidence
- Continuous glucose monitors can significantly improve disease management for insulin-sensitive diabetes patients.
- Only one company, Senseonics, has successfully brought a long-term continuous glucose monitor to market.
- The Eversense CGM system can provide accurate glucose measurements for up to 365 days.
Takeaway
This study shows that special sensors can help people with diabetes check their blood sugar levels for a whole year without needing to change them often.
Methodology
The study involved the development and testing of boronic acid-based fluorescent chemosensors for glucose detection.
Limitations
The sensors initially lost signal in humans due to oxidative deborylation, which was not observed in animal studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website